nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ABCB1—kidney cancer	0.181	1	CbGaD
Enzalutamide—CYP3A5—Temsirolimus—kidney cancer	0.0474	0.0788	CbGbCtD
Enzalutamide—ABCB1—Temsirolimus—kidney cancer	0.0309	0.0513	CbGbCtD
Enzalutamide—CYP2D6—Temsirolimus—kidney cancer	0.0291	0.0483	CbGbCtD
Enzalutamide—CYP3A4—Everolimus—kidney cancer	0.0274	0.0455	CbGbCtD
Enzalutamide—CYP2C8—Pazopanib—kidney cancer	0.024	0.0398	CbGbCtD
Enzalutamide—ALB—Erlotinib—kidney cancer	0.0221	0.0367	CbGbCtD
Enzalutamide—CYP3A4—Temsirolimus—kidney cancer	0.0185	0.0307	CbGbCtD
Enzalutamide—CYP2B6—Sorafenib—kidney cancer	0.0184	0.0305	CbGbCtD
Enzalutamide—CYP3A5—Erlotinib—kidney cancer	0.0178	0.0295	CbGbCtD
Enzalutamide—CYP2C9—Capecitabine—kidney cancer	0.0174	0.0289	CbGbCtD
Enzalutamide—CYP2C8—Erlotinib—kidney cancer	0.0171	0.0284	CbGbCtD
Enzalutamide—CYP3A5—Paclitaxel—kidney cancer	0.0163	0.027	CbGbCtD
Enzalutamide—ABCB1—Pazopanib—kidney cancer	0.0162	0.0269	CbGbCtD
Enzalutamide—CYP2C8—Paclitaxel—kidney cancer	0.0156	0.026	CbGbCtD
Enzalutamide—CYP2D6—Pazopanib—kidney cancer	0.0153	0.0254	CbGbCtD
Enzalutamide—ABCB1—Dactinomycin—kidney cancer	0.0148	0.0246	CbGbCtD
Enzalutamide—CYP3A5—Sorafenib—kidney cancer	0.0145	0.024	CbGbCtD
Enzalutamide—CYP3A5—Vincristine—kidney cancer	0.014	0.0233	CbGbCtD
Enzalutamide—CYP2C8—Sorafenib—kidney cancer	0.0139	0.0231	CbGbCtD
Enzalutamide—ABCB1—Gemcitabine—kidney cancer	0.0117	0.0195	CbGbCtD
Enzalutamide—CYP3A5—Sunitinib—kidney cancer	0.0117	0.0194	CbGbCtD
Enzalutamide—CYP2C19—Sorafenib—kidney cancer	0.0117	0.0194	CbGbCtD
Enzalutamide—ABCB1—Erlotinib—kidney cancer	0.0116	0.0192	CbGbCtD
Enzalutamide—CYP2B6—Doxorubicin—kidney cancer	0.0111	0.0185	CbGbCtD
Enzalutamide—CYP2C9—Paclitaxel—kidney cancer	0.0109	0.0181	CbGbCtD
Enzalutamide—CYP2D6—Erlotinib—kidney cancer	0.0109	0.0181	CbGbCtD
Enzalutamide—ABCB1—Paclitaxel—kidney cancer	0.0106	0.0176	CbGbCtD
Enzalutamide—CYP3A4—Pazopanib—kidney cancer	0.00972	0.0161	CbGbCtD
Enzalutamide—CYP2C9—Sorafenib—kidney cancer	0.00969	0.0161	CbGbCtD
Enzalutamide—ABCB1—Sorafenib—kidney cancer	0.00941	0.0156	CbGbCtD
Enzalutamide—ABCB1—Vinblastine—kidney cancer	0.00929	0.0154	CbGbCtD
Enzalutamide—ABCB1—Vincristine—kidney cancer	0.00913	0.0152	CbGbCtD
Enzalutamide—CYP2D6—Sorafenib—kidney cancer	0.00887	0.0147	CbGbCtD
Enzalutamide—CYP2D6—Vinblastine—kidney cancer	0.00875	0.0145	CbGbCtD
Enzalutamide—ABCB1—Sunitinib—kidney cancer	0.00762	0.0127	CbGbCtD
Enzalutamide—CYP3A4—Erlotinib—kidney cancer	0.00693	0.0115	CbGbCtD
Enzalutamide—CYP3A4—Paclitaxel—kidney cancer	0.00635	0.0105	CbGbCtD
Enzalutamide—ABCB1—Doxorubicin—kidney cancer	0.00571	0.00948	CbGbCtD
Enzalutamide—CYP3A4—Sorafenib—kidney cancer	0.00564	0.00936	CbGbCtD
Enzalutamide—CYP3A4—Vinblastine—kidney cancer	0.00557	0.00924	CbGbCtD
Enzalutamide—CYP3A4—Vincristine—kidney cancer	0.00547	0.00909	CbGbCtD
Enzalutamide—CYP2D6—Doxorubicin—kidney cancer	0.00538	0.00893	CbGbCtD
Enzalutamide—CYP3A4—Sunitinib—kidney cancer	0.00457	0.00758	CbGbCtD
Enzalutamide—CYP3A4—Doxorubicin—kidney cancer	0.00342	0.00568	CbGbCtD
Enzalutamide—CYP2C19—urine—kidney cancer	0.00229	0.139	CbGeAlD
Enzalutamide—CYP2C9—urine—kidney cancer	0.00178	0.108	CbGeAlD
Enzalutamide—CYP3A4—urine—kidney cancer	0.00136	0.082	CbGeAlD
Enzalutamide—CYP2D6—urine—kidney cancer	0.00133	0.0807	CbGeAlD
Enzalutamide—AR—renal system—kidney cancer	0.000605	0.0366	CbGeAlD
Enzalutamide—AR—kidney—kidney cancer	0.000585	0.0354	CbGeAlD
Enzalutamide—AR—cortex of kidney—kidney cancer	0.00057	0.0345	CbGeAlD
Enzalutamide—AR—gonad—kidney cancer	0.000543	0.0329	CbGeAlD
Enzalutamide—AR—cardiac atrium—kidney cancer	0.000542	0.0328	CbGeAlD
Enzalutamide—CYP2C8—renal system—kidney cancer	0.00049	0.0296	CbGeAlD
Enzalutamide—CYP3A5—nephron tubule—kidney cancer	0.000486	0.0294	CbGeAlD
Enzalutamide—CYP2B6—nephron tubule—kidney cancer	0.000483	0.0292	CbGeAlD
Enzalutamide—CYP2C8—kidney—kidney cancer	0.000473	0.0286	CbGeAlD
Enzalutamide—CYP3A5—renal system—kidney cancer	0.000442	0.0267	CbGeAlD
Enzalutamide—CYP2B6—renal system—kidney cancer	0.000439	0.0266	CbGeAlD
Enzalutamide—CYP3A5—kidney—kidney cancer	0.000427	0.0258	CbGeAlD
Enzalutamide—CYP2B6—kidney—kidney cancer	0.000425	0.0257	CbGeAlD
Enzalutamide—CYP3A5—cortex of kidney—kidney cancer	0.000416	0.0252	CbGeAlD
Enzalutamide—CYP2B6—gonad—kidney cancer	0.000394	0.0238	CbGeAlD
Enzalutamide—CYP3A4—renal system—kidney cancer	0.000332	0.0201	CbGeAlD
Enzalutamide—CYP2D6—renal system—kidney cancer	0.000326	0.0197	CbGeAlD
Enzalutamide—CYP3A4—kidney—kidney cancer	0.000321	0.0194	CbGeAlD
Enzalutamide—CYP2D6—kidney—kidney cancer	0.000315	0.0191	CbGeAlD
Enzalutamide—Bronchitis—Paclitaxel—kidney cancer	0.00031	0.00189	CcSEcCtD
Enzalutamide—Nervous system disorder—Erlotinib—kidney cancer	0.000309	0.00188	CcSEcCtD
Enzalutamide—Rhinitis—Gemcitabine—kidney cancer	0.000309	0.00188	CcSEcCtD
Enzalutamide—Thrombocytopenia—Erlotinib—kidney cancer	0.000308	0.00188	CcSEcCtD
Enzalutamide—Skin disorder—Erlotinib—kidney cancer	0.000306	0.00187	CcSEcCtD
Enzalutamide—Pharyngitis—Gemcitabine—kidney cancer	0.000306	0.00186	CcSEcCtD
Enzalutamide—Urinary tract disorder—Gemcitabine—kidney cancer	0.000304	0.00186	CcSEcCtD
Enzalutamide—Oedema peripheral—Gemcitabine—kidney cancer	0.000303	0.00185	CcSEcCtD
Enzalutamide—Connective tissue disorder—Gemcitabine—kidney cancer	0.000303	0.00185	CcSEcCtD
Enzalutamide—Urethral disorder—Gemcitabine—kidney cancer	0.000302	0.00184	CcSEcCtD
Enzalutamide—Neutropenia—Paclitaxel—kidney cancer	0.000301	0.00184	CcSEcCtD
Enzalutamide—Diarrhoea—Temsirolimus—kidney cancer	0.0003	0.00183	CcSEcCtD
Enzalutamide—Hypertension—Sorafenib—kidney cancer	0.0003	0.00183	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.000299	0.00183	CcSEcCtD
Enzalutamide—Leukopenia—Sunitinib—kidney cancer	0.000299	0.00182	CcSEcCtD
Enzalutamide—Pollakiuria—Paclitaxel—kidney cancer	0.000298	0.00182	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000297	0.00181	CcSEcCtD
Enzalutamide—Asthenia—Pazopanib—kidney cancer	0.000297	0.00181	CcSEcCtD
Enzalutamide—Arthralgia—Sorafenib—kidney cancer	0.000296	0.0018	CcSEcCtD
Enzalutamide—Insomnia—Everolimus—kidney cancer	0.000295	0.0018	CcSEcCtD
Enzalutamide—Angiopathy—Vincristine—kidney cancer	0.000295	0.0018	CcSEcCtD
Enzalutamide—Paraesthesia—Vinblastine—kidney cancer	0.000294	0.0018	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000294	0.00179	CcSEcCtD
Enzalutamide—Paraesthesia—Everolimus—kidney cancer	0.000293	0.00179	CcSEcCtD
Enzalutamide—Pruritus—Pazopanib—kidney cancer	0.000293	0.00178	CcSEcCtD
Enzalutamide—Dizziness—Temsirolimus—kidney cancer	0.00029	0.00177	CcSEcCtD
Enzalutamide—Convulsion—Sunitinib—kidney cancer	0.00029	0.00177	CcSEcCtD
Enzalutamide—Pneumonia—Paclitaxel—kidney cancer	0.000289	0.00176	CcSEcCtD
Enzalutamide—Hypertension—Sunitinib—kidney cancer	0.000289	0.00176	CcSEcCtD
Enzalutamide—Infestation NOS—Paclitaxel—kidney cancer	0.000287	0.00175	CcSEcCtD
Enzalutamide—Infestation—Paclitaxel—kidney cancer	0.000287	0.00175	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000287	0.00175	CcSEcCtD
Enzalutamide—Insomnia—Erlotinib—kidney cancer	0.000285	0.00174	CcSEcCtD
Enzalutamide—Arthralgia—Sunitinib—kidney cancer	0.000285	0.00174	CcSEcCtD
Enzalutamide—Mental disorder—Vincristine—kidney cancer	0.000284	0.00174	CcSEcCtD
Enzalutamide—Leukopenia—Dactinomycin—kidney cancer	0.000283	0.00173	CcSEcCtD
Enzalutamide—Diarrhoea—Pazopanib—kidney cancer	0.000283	0.00173	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000283	0.00172	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Everolimus—kidney cancer	0.000282	0.00172	CcSEcCtD
Enzalutamide—Infection—Sorafenib—kidney cancer	0.000282	0.00172	CcSEcCtD
Enzalutamide—Fatigue—Everolimus—kidney cancer	0.000282	0.00172	CcSEcCtD
Enzalutamide—Dry skin—Capecitabine—kidney cancer	0.00028	0.00171	CcSEcCtD
Enzalutamide—Angiopathy—Gemcitabine—kidney cancer	0.000279	0.0017	CcSEcCtD
Enzalutamide—Nervous system disorder—Sorafenib—kidney cancer	0.000278	0.0017	CcSEcCtD
Enzalutamide—Thrombocytopenia—Sorafenib—kidney cancer	0.000278	0.00169	CcSEcCtD
Enzalutamide—Skin disorder—Sorafenib—kidney cancer	0.000275	0.00168	CcSEcCtD
Enzalutamide—Headache—Temsirolimus—kidney cancer	0.000275	0.00168	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Doxorubicin—kidney cancer	0.000275	0.00168	CcSEcCtD
Enzalutamide—Haematuria—Paclitaxel—kidney cancer	0.000274	0.00167	CcSEcCtD
Enzalutamide—Nasopharyngitis—Capecitabine—kidney cancer	0.000274	0.00167	CcSEcCtD
Enzalutamide—Dizziness—Pazopanib—kidney cancer	0.000273	0.00167	CcSEcCtD
Enzalutamide—Back pain—Vincristine—kidney cancer	0.000273	0.00167	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000272	0.00166	CcSEcCtD
Enzalutamide—Fatigue—Erlotinib—kidney cancer	0.000272	0.00166	CcSEcCtD
Enzalutamide—Epistaxis—Paclitaxel—kidney cancer	0.000271	0.00165	CcSEcCtD
Enzalutamide—Infection—Sunitinib—kidney cancer	0.000271	0.00165	CcSEcCtD
Enzalutamide—Muscular weakness—Capecitabine—kidney cancer	0.00027	0.00165	CcSEcCtD
Enzalutamide—Sinusitis—Paclitaxel—kidney cancer	0.00027	0.00164	CcSEcCtD
Enzalutamide—Nervous system disorder—Sunitinib—kidney cancer	0.000267	0.00163	CcSEcCtD
Enzalutamide—Thrombocytopenia—Sunitinib—kidney cancer	0.000267	0.00163	CcSEcCtD
Enzalutamide—Skin disorder—Sunitinib—kidney cancer	0.000265	0.00162	CcSEcCtD
Enzalutamide—Back pain—Gemcitabine—kidney cancer	0.000259	0.00158	CcSEcCtD
Enzalutamide—Headache—Pazopanib—kidney cancer	0.000259	0.00158	CcSEcCtD
Enzalutamide—Rhinitis—Paclitaxel—kidney cancer	0.000259	0.00158	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000258	0.00158	CcSEcCtD
Enzalutamide—ABCB1—nephron tubule—kidney cancer	0.000258	0.0156	CbGeAlD
Enzalutamide—Hypoaesthesia—Paclitaxel—kidney cancer	0.000257	0.00157	CcSEcCtD
Enzalutamide—Infection—Dactinomycin—kidney cancer	0.000257	0.00156	CcSEcCtD
Enzalutamide—Pharyngitis—Paclitaxel—kidney cancer	0.000256	0.00156	CcSEcCtD
Enzalutamide—Urinary tract disorder—Paclitaxel—kidney cancer	0.000255	0.00155	CcSEcCtD
Enzalutamide—Bronchitis—Capecitabine—kidney cancer	0.000254	0.00155	CcSEcCtD
Enzalutamide—Oedema peripheral—Paclitaxel—kidney cancer	0.000254	0.00155	CcSEcCtD
Enzalutamide—Vertigo—Vincristine—kidney cancer	0.000254	0.00155	CcSEcCtD
Enzalutamide—Connective tissue disorder—Paclitaxel—kidney cancer	0.000253	0.00155	CcSEcCtD
Enzalutamide—Leukopenia—Vincristine—kidney cancer	0.000253	0.00154	CcSEcCtD
Enzalutamide—Urethral disorder—Paclitaxel—kidney cancer	0.000253	0.00154	CcSEcCtD
Enzalutamide—Thrombocytopenia—Dactinomycin—kidney cancer	0.000253	0.00154	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000248	0.00152	CcSEcCtD
Enzalutamide—Neutropenia—Capecitabine—kidney cancer	0.000247	0.00151	CcSEcCtD
Enzalutamide—Insomnia—Sunitinib—kidney cancer	0.000247	0.0015	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000246	0.0015	CcSEcCtD
Enzalutamide—Paraesthesia—Sunitinib—kidney cancer	0.000245	0.00149	CcSEcCtD
Enzalutamide—Convulsion—Vincristine—kidney cancer	0.000245	0.00149	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000245	0.00149	CcSEcCtD
Enzalutamide—Fatigue—Sorafenib—kidney cancer	0.000244	0.00149	CcSEcCtD
Enzalutamide—Hypertension—Vincristine—kidney cancer	0.000244	0.00149	CcSEcCtD
Enzalutamide—Leukopenia—Gemcitabine—kidney cancer	0.00024	0.00146	CcSEcCtD
Enzalutamide—Pneumonia—Capecitabine—kidney cancer	0.000237	0.00145	CcSEcCtD
Enzalutamide—Infestation NOS—Capecitabine—kidney cancer	0.000236	0.00144	CcSEcCtD
Enzalutamide—Infestation—Capecitabine—kidney cancer	0.000236	0.00144	CcSEcCtD
Enzalutamide—Sepsis—Doxorubicin—kidney cancer	0.000236	0.00144	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000235	0.00144	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000235	0.00143	CcSEcCtD
Enzalutamide—Asthenia—Vinblastine—kidney cancer	0.000235	0.00143	CcSEcCtD
Enzalutamide—Fatigue—Sunitinib—kidney cancer	0.000235	0.00143	CcSEcCtD
Enzalutamide—ABCB1—renal system—kidney cancer	0.000235	0.0142	CbGeAlD
Enzalutamide—Asthenia—Everolimus—kidney cancer	0.000234	0.00143	CcSEcCtD
Enzalutamide—Angiopathy—Paclitaxel—kidney cancer	0.000234	0.00143	CcSEcCtD
Enzalutamide—Hypertension—Gemcitabine—kidney cancer	0.000232	0.00141	CcSEcCtD
Enzalutamide—Pruritus—Everolimus—kidney cancer	0.000231	0.00141	CcSEcCtD
Enzalutamide—Infection—Vincristine—kidney cancer	0.000229	0.0014	CcSEcCtD
Enzalutamide—Arthralgia—Gemcitabine—kidney cancer	0.000228	0.00139	CcSEcCtD
Enzalutamide—ABCB1—kidney—kidney cancer	0.000227	0.0137	CbGeAlD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000227	0.00138	CcSEcCtD
Enzalutamide—Nervous system disorder—Vincristine—kidney cancer	0.000226	0.00138	CcSEcCtD
Enzalutamide—Asthenia—Erlotinib—kidney cancer	0.000226	0.00138	CcSEcCtD
Enzalutamide—Mental disorder—Paclitaxel—kidney cancer	0.000226	0.00138	CcSEcCtD
Enzalutamide—Thrombocytopenia—Vincristine—kidney cancer	0.000226	0.00138	CcSEcCtD
Enzalutamide—Haematuria—Capecitabine—kidney cancer	0.000225	0.00137	CcSEcCtD
Enzalutamide—Diarrhoea—Vinblastine—kidney cancer	0.000224	0.00137	CcSEcCtD
Enzalutamide—Diarrhoea—Everolimus—kidney cancer	0.000223	0.00136	CcSEcCtD
Enzalutamide—Pruritus—Erlotinib—kidney cancer	0.000223	0.00136	CcSEcCtD
Enzalutamide—Fatigue—Dactinomycin—kidney cancer	0.000223	0.00136	CcSEcCtD
Enzalutamide—Epistaxis—Capecitabine—kidney cancer	0.000222	0.00136	CcSEcCtD
Enzalutamide—ABCB1—cortex of kidney—kidney cancer	0.000221	0.0134	CbGeAlD
Enzalutamide—Infection—Gemcitabine—kidney cancer	0.000217	0.00133	CcSEcCtD
Enzalutamide—Back pain—Paclitaxel—kidney cancer	0.000217	0.00132	CcSEcCtD
Enzalutamide—Dizziness—Vinblastine—kidney cancer	0.000217	0.00132	CcSEcCtD
Enzalutamide—Dizziness—Everolimus—kidney cancer	0.000216	0.00132	CcSEcCtD
Enzalutamide—Diarrhoea—Erlotinib—kidney cancer	0.000216	0.00131	CcSEcCtD
Enzalutamide—Nervous system disorder—Gemcitabine—kidney cancer	0.000215	0.00131	CcSEcCtD
Enzalutamide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000214	0.00131	CcSEcCtD
Enzalutamide—Skin disorder—Gemcitabine—kidney cancer	0.000213	0.0013	CcSEcCtD
Enzalutamide—Rhinitis—Capecitabine—kidney cancer	0.000212	0.00129	CcSEcCtD
Enzalutamide—Hot flush—Doxorubicin—kidney cancer	0.000211	0.00129	CcSEcCtD
Enzalutamide—Hypoaesthesia—Capecitabine—kidney cancer	0.000211	0.00128	CcSEcCtD
Enzalutamide—ABCB1—gonad—kidney cancer	0.000211	0.0127	CbGeAlD
Enzalutamide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00021	0.00128	CcSEcCtD
Enzalutamide—Pharyngitis—Capecitabine—kidney cancer	0.00021	0.00128	CcSEcCtD
Enzalutamide—Urinary tract disorder—Capecitabine—kidney cancer	0.000209	0.00127	CcSEcCtD
Enzalutamide—Menopausal symptoms—Doxorubicin—kidney cancer	0.000209	0.00127	CcSEcCtD
Enzalutamide—Insomnia—Vincristine—kidney cancer	0.000209	0.00127	CcSEcCtD
Enzalutamide—Oedema peripheral—Capecitabine—kidney cancer	0.000208	0.00127	CcSEcCtD
Enzalutamide—Dizziness—Erlotinib—kidney cancer	0.000208	0.00127	CcSEcCtD
Enzalutamide—Connective tissue disorder—Capecitabine—kidney cancer	0.000208	0.00127	CcSEcCtD
Enzalutamide—Urethral disorder—Capecitabine—kidney cancer	0.000207	0.00127	CcSEcCtD
Enzalutamide—Paraesthesia—Vincristine—kidney cancer	0.000207	0.00126	CcSEcCtD
Enzalutamide—Headache—Vinblastine—kidney cancer	0.000205	0.00125	CcSEcCtD
Enzalutamide—Headache—Everolimus—kidney cancer	0.000205	0.00125	CcSEcCtD
Enzalutamide—Asthenia—Sorafenib—kidney cancer	0.000203	0.00124	CcSEcCtD
Enzalutamide—Vertigo—Paclitaxel—kidney cancer	0.000202	0.00123	CcSEcCtD
Enzalutamide—Leukopenia—Paclitaxel—kidney cancer	0.000201	0.00123	CcSEcCtD
Enzalutamide—Pruritus—Sorafenib—kidney cancer	0.000201	0.00122	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000199	0.00122	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Vincristine—kidney cancer	0.000199	0.00121	CcSEcCtD
Enzalutamide—Fatigue—Vincristine—kidney cancer	0.000199	0.00121	CcSEcCtD
Enzalutamide—Insomnia—Gemcitabine—kidney cancer	0.000198	0.00121	CcSEcCtD
Enzalutamide—Headache—Erlotinib—kidney cancer	0.000197	0.0012	CcSEcCtD
Enzalutamide—Paraesthesia—Gemcitabine—kidney cancer	0.000197	0.0012	CcSEcCtD
Enzalutamide—Asthenia—Sunitinib—kidney cancer	0.000196	0.00119	CcSEcCtD
Enzalutamide—Convulsion—Paclitaxel—kidney cancer	0.000195	0.00119	CcSEcCtD
Enzalutamide—Diarrhoea—Sorafenib—kidney cancer	0.000194	0.00118	CcSEcCtD
Enzalutamide—Hypertension—Paclitaxel—kidney cancer	0.000194	0.00118	CcSEcCtD
Enzalutamide—Pruritus—Sunitinib—kidney cancer	0.000193	0.00118	CcSEcCtD
Enzalutamide—Angiopathy—Capecitabine—kidney cancer	0.000192	0.00117	CcSEcCtD
Enzalutamide—Arthralgia—Paclitaxel—kidney cancer	0.000191	0.00117	CcSEcCtD
Enzalutamide—Anxiety—Paclitaxel—kidney cancer	0.00019	0.00116	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00019	0.00116	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000189	0.00115	CcSEcCtD
Enzalutamide—Fatigue—Gemcitabine—kidney cancer	0.000189	0.00115	CcSEcCtD
Enzalutamide—Dizziness—Sorafenib—kidney cancer	0.000187	0.00114	CcSEcCtD
Enzalutamide—Diarrhoea—Sunitinib—kidney cancer	0.000187	0.00114	CcSEcCtD
Enzalutamide—Mental disorder—Capecitabine—kidney cancer	0.000185	0.00113	CcSEcCtD
Enzalutamide—Asthenia—Dactinomycin—kidney cancer	0.000185	0.00113	CcSEcCtD
Enzalutamide—Infection—Paclitaxel—kidney cancer	0.000182	0.00111	CcSEcCtD
Enzalutamide—Dry skin—Doxorubicin—kidney cancer	0.000181	0.0011	CcSEcCtD
Enzalutamide—Dizziness—Sunitinib—kidney cancer	0.00018	0.0011	CcSEcCtD
Enzalutamide—Nervous system disorder—Paclitaxel—kidney cancer	0.00018	0.0011	CcSEcCtD
Enzalutamide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000179	0.00109	CcSEcCtD
Enzalutamide—Back pain—Capecitabine—kidney cancer	0.000178	0.00109	CcSEcCtD
Enzalutamide—Skin disorder—Paclitaxel—kidney cancer	0.000178	0.00109	CcSEcCtD
Enzalutamide—Headache—Sorafenib—kidney cancer	0.000178	0.00108	CcSEcCtD
Enzalutamide—Diarrhoea—Dactinomycin—kidney cancer	0.000177	0.00108	CcSEcCtD
Enzalutamide—Nasopharyngitis—Doxorubicin—kidney cancer	0.000176	0.00108	CcSEcCtD
Enzalutamide—Muscular weakness—Doxorubicin—kidney cancer	0.000174	0.00106	CcSEcCtD
Enzalutamide—Headache—Sunitinib—kidney cancer	0.000171	0.00104	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000167	0.00102	CcSEcCtD
Enzalutamide—Insomnia—Paclitaxel—kidney cancer	0.000166	0.00101	CcSEcCtD
Enzalutamide—Vertigo—Capecitabine—kidney cancer	0.000166	0.00101	CcSEcCtD
Enzalutamide—Asthenia—Vincristine—kidney cancer	0.000166	0.00101	CcSEcCtD
Enzalutamide—Leukopenia—Capecitabine—kidney cancer	0.000165	0.00101	CcSEcCtD
Enzalutamide—Paraesthesia—Paclitaxel—kidney cancer	0.000165	0.001	CcSEcCtD
Enzalutamide—Bronchitis—Doxorubicin—kidney cancer	0.000164	0.001	CcSEcCtD
Enzalutamide—Neutropenia—Doxorubicin—kidney cancer	0.000159	0.000972	CcSEcCtD
Enzalutamide—Hypertension—Capecitabine—kidney cancer	0.000159	0.00097	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000158	0.000966	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000158	0.000965	CcSEcCtD
Enzalutamide—Fatigue—Paclitaxel—kidney cancer	0.000158	0.000964	CcSEcCtD
Enzalutamide—Diarrhoea—Vincristine—kidney cancer	0.000158	0.000963	CcSEcCtD
Enzalutamide—Pollakiuria—Doxorubicin—kidney cancer	0.000157	0.00096	CcSEcCtD
Enzalutamide—Asthenia—Gemcitabine—kidney cancer	0.000157	0.000958	CcSEcCtD
Enzalutamide—Arthralgia—Capecitabine—kidney cancer	0.000157	0.000957	CcSEcCtD
Enzalutamide—Anxiety—Capecitabine—kidney cancer	0.000156	0.000954	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000156	0.00095	CcSEcCtD
Enzalutamide—Pruritus—Gemcitabine—kidney cancer	0.000155	0.000944	CcSEcCtD
Enzalutamide—Pneumonia—Doxorubicin—kidney cancer	0.000153	0.000932	CcSEcCtD
Enzalutamide—Dizziness—Vincristine—kidney cancer	0.000153	0.000931	CcSEcCtD
Enzalutamide—Infestation NOS—Doxorubicin—kidney cancer	0.000152	0.000927	CcSEcCtD
Enzalutamide—Infestation—Doxorubicin—kidney cancer	0.000152	0.000927	CcSEcCtD
Enzalutamide—Diarrhoea—Gemcitabine—kidney cancer	0.00015	0.000913	CcSEcCtD
Enzalutamide—Infection—Capecitabine—kidney cancer	0.000149	0.000911	CcSEcCtD
Enzalutamide—Nervous system disorder—Capecitabine—kidney cancer	0.000147	0.0009	CcSEcCtD
Enzalutamide—Thrombocytopenia—Capecitabine—kidney cancer	0.000147	0.000898	CcSEcCtD
Enzalutamide—Skin disorder—Capecitabine—kidney cancer	0.000146	0.000891	CcSEcCtD
Enzalutamide—Haematuria—Doxorubicin—kidney cancer	0.000145	0.000884	CcSEcCtD
Enzalutamide—Headache—Vincristine—kidney cancer	0.000145	0.000882	CcSEcCtD
Enzalutamide—Epistaxis—Doxorubicin—kidney cancer	0.000143	0.000874	CcSEcCtD
Enzalutamide—Sinusitis—Doxorubicin—kidney cancer	0.000143	0.00087	CcSEcCtD
Enzalutamide—Headache—Gemcitabine—kidney cancer	0.000137	0.000836	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000137	0.000836	CcSEcCtD
Enzalutamide—Rhinitis—Doxorubicin—kidney cancer	0.000137	0.000834	CcSEcCtD
Enzalutamide—Insomnia—Capecitabine—kidney cancer	0.000136	0.00083	CcSEcCtD
Enzalutamide—Hypoaesthesia—Doxorubicin—kidney cancer	0.000136	0.000828	CcSEcCtD
Enzalutamide—Pharyngitis—Doxorubicin—kidney cancer	0.000135	0.000826	CcSEcCtD
Enzalutamide—Paraesthesia—Capecitabine—kidney cancer	0.000135	0.000824	CcSEcCtD
Enzalutamide—Urinary tract disorder—Doxorubicin—kidney cancer	0.000135	0.000822	CcSEcCtD
Enzalutamide—Oedema peripheral—Doxorubicin—kidney cancer	0.000134	0.00082	CcSEcCtD
Enzalutamide—Connective tissue disorder—Doxorubicin—kidney cancer	0.000134	0.000818	CcSEcCtD
Enzalutamide—Urethral disorder—Doxorubicin—kidney cancer	0.000134	0.000816	CcSEcCtD
Enzalutamide—Asthenia—Paclitaxel—kidney cancer	0.000131	0.000802	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00013	0.000792	CcSEcCtD
Enzalutamide—Fatigue—Capecitabine—kidney cancer	0.00013	0.000791	CcSEcCtD
Enzalutamide—Pruritus—Paclitaxel—kidney cancer	0.00013	0.000791	CcSEcCtD
Enzalutamide—Diarrhoea—Paclitaxel—kidney cancer	0.000125	0.000765	CcSEcCtD
Enzalutamide—Angiopathy—Doxorubicin—kidney cancer	0.000124	0.000755	CcSEcCtD
Enzalutamide—Dizziness—Paclitaxel—kidney cancer	0.000121	0.000739	CcSEcCtD
Enzalutamide—Mental disorder—Doxorubicin—kidney cancer	0.00012	0.000729	CcSEcCtD
Enzalutamide—Back pain—Doxorubicin—kidney cancer	0.000115	0.000701	CcSEcCtD
Enzalutamide—Headache—Paclitaxel—kidney cancer	0.000115	0.0007	CcSEcCtD
Enzalutamide—Asthenia—Capecitabine—kidney cancer	0.000108	0.000658	CcSEcCtD
Enzalutamide—Vertigo—Doxorubicin—kidney cancer	0.000107	0.000651	CcSEcCtD
Enzalutamide—Pruritus—Capecitabine—kidney cancer	0.000106	0.000649	CcSEcCtD
Enzalutamide—Leukopenia—Doxorubicin—kidney cancer	0.000106	0.000648	CcSEcCtD
Enzalutamide—Convulsion—Doxorubicin—kidney cancer	0.000103	0.000628	CcSEcCtD
Enzalutamide—Diarrhoea—Capecitabine—kidney cancer	0.000103	0.000628	CcSEcCtD
Enzalutamide—Hypertension—Doxorubicin—kidney cancer	0.000103	0.000625	CcSEcCtD
Enzalutamide—Arthralgia—Doxorubicin—kidney cancer	0.000101	0.000617	CcSEcCtD
Enzalutamide—Anxiety—Doxorubicin—kidney cancer	0.000101	0.000615	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.0001	0.000613	CcSEcCtD
Enzalutamide—Dizziness—Capecitabine—kidney cancer	9.94e-05	0.000607	CcSEcCtD
Enzalutamide—Infection—Doxorubicin—kidney cancer	9.63e-05	0.000587	CcSEcCtD
Enzalutamide—Nervous system disorder—Doxorubicin—kidney cancer	9.5e-05	0.00058	CcSEcCtD
Enzalutamide—Thrombocytopenia—Doxorubicin—kidney cancer	9.49e-05	0.000579	CcSEcCtD
Enzalutamide—Headache—Capecitabine—kidney cancer	9.42e-05	0.000575	CcSEcCtD
Enzalutamide—Skin disorder—Doxorubicin—kidney cancer	9.41e-05	0.000574	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.83e-05	0.000539	CcSEcCtD
Enzalutamide—Insomnia—Doxorubicin—kidney cancer	8.77e-05	0.000535	CcSEcCtD
Enzalutamide—Paraesthesia—Doxorubicin—kidney cancer	8.7e-05	0.000531	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.37e-05	0.00051	CcSEcCtD
Enzalutamide—Fatigue—Doxorubicin—kidney cancer	8.36e-05	0.00051	CcSEcCtD
Enzalutamide—Asthenia—Doxorubicin—kidney cancer	6.95e-05	0.000424	CcSEcCtD
Enzalutamide—Pruritus—Doxorubicin—kidney cancer	6.86e-05	0.000418	CcSEcCtD
Enzalutamide—Diarrhoea—Doxorubicin—kidney cancer	6.63e-05	0.000405	CcSEcCtD
Enzalutamide—Dizziness—Doxorubicin—kidney cancer	6.41e-05	0.000391	CcSEcCtD
Enzalutamide—Headache—Doxorubicin—kidney cancer	6.07e-05	0.00037	CcSEcCtD
Enzalutamide—CYP2D6—Metabolism—CA2—kidney cancer	1.34e-05	0.000368	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CA2—kidney cancer	1.33e-05	0.000365	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—MYC—kidney cancer	1.32e-05	0.000364	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.32e-05	0.000363	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.31e-05	0.000359	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALAD—kidney cancer	1.31e-05	0.000358	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PGK1—kidney cancer	1.3e-05	0.000356	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.3e-05	0.000356	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALAD—kidney cancer	1.29e-05	0.000355	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.27e-05	0.00035	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—LDHB—kidney cancer	1.27e-05	0.00035	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SLC5A3—kidney cancer	1.27e-05	0.000348	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PGK1—kidney cancer	1.27e-05	0.000348	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PDHB—kidney cancer	1.26e-05	0.000347	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.26e-05	0.000347	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—POMC—kidney cancer	1.26e-05	0.000346	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.25e-05	0.000342	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—LDHB—kidney cancer	1.24e-05	0.000341	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CRABP1—kidney cancer	1.24e-05	0.000341	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.24e-05	0.000341	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CA9—kidney cancer	1.24e-05	0.00034	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.23e-05	0.000339	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CA9—kidney cancer	1.23e-05	0.000338	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CRABP1—kidney cancer	1.21e-05	0.000333	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.21e-05	0.000332	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.2e-05	0.00033	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.2e-05	0.000329	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PGK1—kidney cancer	1.19e-05	0.000328	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.19e-05	0.000328	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CCBL1—kidney cancer	1.19e-05	0.000326	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.18e-05	0.000325	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PGK1—kidney cancer	1.18e-05	0.000325	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.18e-05	0.000324	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—LDHB—kidney cancer	1.17e-05	0.000322	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—LDHB—kidney cancer	1.16e-05	0.000319	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ITPR2—kidney cancer	1.15e-05	0.000317	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.13e-05	0.000312	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ITPR2—kidney cancer	1.13e-05	0.00031	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.12e-05	0.000307	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CA9—kidney cancer	1.1e-05	0.000303	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.09e-05	0.000298	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.08e-05	0.000297	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.08e-05	0.000296	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CA9—kidney cancer	1.08e-05	0.000296	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.06e-05	0.000292	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ACHE—kidney cancer	1.05e-05	0.000289	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTT1—kidney cancer	1.05e-05	0.000289	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CRABP1—kidney cancer	1.05e-05	0.000289	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CRABP1—kidney cancer	1.05e-05	0.000287	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPAT—kidney cancer	1.03e-05	0.000283	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.03e-05	0.000283	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTT1—kidney cancer	1.03e-05	0.000283	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ACHE—kidney cancer	1.03e-05	0.000283	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CA9—kidney cancer	1.01e-05	0.000279	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CA9—kidney cancer	1.01e-05	0.000276	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1e-05	0.000276	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—SCARB1—kidney cancer	9.96e-06	0.000274	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS1—kidney cancer	9.86e-06	0.000271	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.83e-06	0.00027	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ITPR2—kidney cancer	9.77e-06	0.000268	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—SCARB1—kidney cancer	9.74e-06	0.000268	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ITPR2—kidney cancer	9.72e-06	0.000267	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PSMD7—kidney cancer	9.67e-06	0.000266	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS1—kidney cancer	9.64e-06	0.000265	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—FH—kidney cancer	9.57e-06	0.000263	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APRT—kidney cancer	9.57e-06	0.000263	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PSMD7—kidney cancer	9.46e-06	0.00026	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CRABP1—kidney cancer	9.38e-06	0.000258	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	9.37e-06	0.000257	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.22e-06	0.000253	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—BCHE—kidney cancer	9.17e-06	0.000252	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CRABP1—kidney cancer	9.16e-06	0.000252	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—SLC5A5—kidney cancer	9.06e-06	0.000249	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.01e-06	0.000247	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GPC3—kidney cancer	9e-06	0.000247	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—BCHE—kidney cancer	8.96e-06	0.000246	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.96e-06	0.000246	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	8.92e-06	0.000245	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTT1—kidney cancer	8.91e-06	0.000245	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ACHE—kidney cancer	8.91e-06	0.000245	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTT1—kidney cancer	8.86e-06	0.000243	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ACHE—kidney cancer	8.86e-06	0.000243	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—SLC5A5—kidney cancer	8.85e-06	0.000243	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CA2—kidney cancer	8.76e-06	0.000241	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—SLC2A1—kidney cancer	8.75e-06	0.00024	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ITPR2—kidney cancer	8.72e-06	0.00024	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CRABP1—kidney cancer	8.63e-06	0.000237	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CRABP1—kidney cancer	8.56e-06	0.000235	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—SLC2A1—kidney cancer	8.55e-06	0.000235	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALAD—kidney cancer	8.53e-06	0.000234	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ITPR2—kidney cancer	8.51e-06	0.000234	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—SCARB1—kidney cancer	8.44e-06	0.000232	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—SCARB1—kidney cancer	8.39e-06	0.00023	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS1—kidney cancer	8.35e-06	0.000229	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.33e-06	0.000229	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS1—kidney cancer	8.3e-06	0.000228	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PSMD7—kidney cancer	8.19e-06	0.000225	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PSMD7—kidney cancer	8.14e-06	0.000224	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.14e-06	0.000224	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—RAF1—kidney cancer	8.11e-06	0.000223	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.04e-06	0.000221	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ITPR2—kidney cancer	8.02e-06	0.00022	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ACHE—kidney cancer	7.95e-06	0.000218	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTT1—kidney cancer	7.95e-06	0.000218	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ITPR2—kidney cancer	7.95e-06	0.000218	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.8e-06	0.000214	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PGK1—kidney cancer	7.8e-06	0.000214	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ACHE—kidney cancer	7.76e-06	0.000213	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTT1—kidney cancer	7.76e-06	0.000213	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—BCHE—kidney cancer	7.76e-06	0.000213	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—BCHE—kidney cancer	7.72e-06	0.000212	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—SLC5A5—kidney cancer	7.67e-06	0.000211	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LDHB—kidney cancer	7.65e-06	0.00021	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—SLC5A5—kidney cancer	7.63e-06	0.000209	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SCARB1—kidney cancer	7.53e-06	0.000207	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS1—kidney cancer	7.45e-06	0.000205	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—SLC2A1—kidney cancer	7.41e-06	0.000203	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—SLC2A1—kidney cancer	7.36e-06	0.000202	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SCARB1—kidney cancer	7.35e-06	0.000202	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.33e-06	0.000201	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTT1—kidney cancer	7.32e-06	0.000201	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ACHE—kidney cancer	7.32e-06	0.000201	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PSMD7—kidney cancer	7.31e-06	0.000201	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTP1—kidney cancer	7.3e-06	0.0002	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS1—kidney cancer	7.28e-06	0.0002	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IL2—kidney cancer	7.27e-06	0.0002	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTT1—kidney cancer	7.25e-06	0.000199	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ACHE—kidney cancer	7.25e-06	0.000199	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.19e-06	0.000197	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.15e-06	0.000196	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PSMD7—kidney cancer	7.13e-06	0.000196	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTP1—kidney cancer	7.13e-06	0.000196	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	7.02e-06	0.000193	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—BCHE—kidney cancer	6.93e-06	0.00019	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SCARB1—kidney cancer	6.93e-06	0.00019	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ABCB1—kidney cancer	6.91e-06	0.00019	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SCARB1—kidney cancer	6.87e-06	0.000189	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS1—kidney cancer	6.86e-06	0.000188	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SLC5A5—kidney cancer	6.85e-06	0.000188	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS1—kidney cancer	6.8e-06	0.000187	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—BCHE—kidney cancer	6.76e-06	0.000186	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ABCB1—kidney cancer	6.75e-06	0.000185	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PSMD7—kidney cancer	6.72e-06	0.000185	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTM1—kidney cancer	6.71e-06	0.000184	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SLC5A5—kidney cancer	6.68e-06	0.000184	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PSMD7—kidney cancer	6.67e-06	0.000183	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CA9—kidney cancer	6.64e-06	0.000182	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SLC2A1—kidney cancer	6.61e-06	0.000182	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MAPK3—kidney cancer	6.56e-06	0.00018	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTM1—kidney cancer	6.55e-06	0.00018	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SLC2A1—kidney cancer	6.45e-06	0.000177	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.41e-06	0.000176	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MYC—kidney cancer	6.38e-06	0.000175	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—BCHE—kidney cancer	6.37e-06	0.000175	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP1A1—kidney cancer	6.36e-06	0.000175	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—BCHE—kidney cancer	6.32e-06	0.000174	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SLC5A5—kidney cancer	6.3e-06	0.000173	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.27e-06	0.000172	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.24e-06	0.000171	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.23e-06	0.000171	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP1A1—kidney cancer	6.21e-06	0.000171	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—kidney cancer	6.18e-06	0.00017	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTP1—kidney cancer	6.18e-06	0.00017	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.15e-06	0.000169	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTP1—kidney cancer	6.14e-06	0.000169	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SLC2A1—kidney cancer	6.08e-06	0.000167	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.03e-06	0.000166	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.85e-06	0.000161	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MAPK3—kidney cancer	5.85e-06	0.000161	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ABCB1—kidney cancer	5.85e-06	0.000161	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ABCB1—kidney cancer	5.81e-06	0.00016	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTM1—kidney cancer	5.68e-06	0.000156	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTM1—kidney cancer	5.64e-06	0.000155	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CRABP1—kidney cancer	5.64e-06	0.000155	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.59e-06	0.000154	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MAPK1—kidney cancer	5.56e-06	0.000153	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTP1—kidney cancer	5.51e-06	0.000151	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTP1—kidney cancer	5.38e-06	0.000148	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.38e-06	0.000148	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP1A1—kidney cancer	5.35e-06	0.000147	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—KRAS—kidney cancer	5.26e-06	0.000144	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ITPR2—kidney cancer	5.25e-06	0.000144	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ABCB1—kidney cancer	5.22e-06	0.000143	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.1e-06	0.00014	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTP1—kidney cancer	5.07e-06	0.000139	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTM1—kidney cancer	5.07e-06	0.000139	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTP1—kidney cancer	5.03e-06	0.000138	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTM1—kidney cancer	4.95e-06	0.000136	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CA—kidney cancer	4.83e-06	0.000133	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP1A1—kidney cancer	4.8e-06	0.000132	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ABCB1—kidney cancer	4.8e-06	0.000132	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTT1—kidney cancer	4.78e-06	0.000131	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ACHE—kidney cancer	4.78e-06	0.000131	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ABCB1—kidney cancer	4.76e-06	0.000131	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—POMC—kidney cancer	4.74e-06	0.00013	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP1A1—kidney cancer	4.69e-06	0.000129	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—kidney cancer	4.67e-06	0.000128	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTM1—kidney cancer	4.66e-06	0.000128	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—POMC—kidney cancer	4.63e-06	0.000127	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTM1—kidney cancer	4.62e-06	0.000127	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SCARB1—kidney cancer	4.53e-06	0.000124	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS1—kidney cancer	4.48e-06	0.000123	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.42e-06	0.000121	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.42e-06	0.000121	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.4e-06	0.000121	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PSMD7—kidney cancer	4.4e-06	0.000121	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.38e-06	0.00012	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—BCHE—kidney cancer	4.17e-06	0.000114	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.12e-06	0.000113	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—POMC—kidney cancer	4.01e-06	0.00011	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—POMC—kidney cancer	3.99e-06	0.00011	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.98e-06	0.000109	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.95e-06	0.000108	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—kidney cancer	3.78e-06	0.000104	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—kidney cancer	3.69e-06	0.000101	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.6e-06	9.88e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—POMC—kidney cancer	3.58e-06	9.84e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—POMC—kidney cancer	3.5e-06	9.6e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTP1—kidney cancer	3.32e-06	9.11e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTEN—kidney cancer	3.3e-06	9.05e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—POMC—kidney cancer	3.29e-06	9.05e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—POMC—kidney cancer	3.27e-06	8.97e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTEN—kidney cancer	3.22e-06	8.85e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—kidney cancer	3.2e-06	8.79e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—kidney cancer	3.18e-06	8.74e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCB1—kidney cancer	3.14e-06	8.62e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTM1—kidney cancer	3.05e-06	8.37e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.89e-06	7.93e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—kidney cancer	2.86e-06	7.85e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTEN—kidney cancer	2.79e-06	7.67e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—kidney cancer	2.79e-06	7.66e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTEN—kidney cancer	2.78e-06	7.62e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—kidney cancer	2.63e-06	7.22e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—kidney cancer	2.6e-06	7.15e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTEN—kidney cancer	2.49e-06	6.84e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTEN—kidney cancer	2.43e-06	6.68e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CA—kidney cancer	2.33e-06	6.39e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTEN—kidney cancer	2.29e-06	6.29e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CA—kidney cancer	2.27e-06	6.24e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTEN—kidney cancer	2.27e-06	6.24e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—POMC—kidney cancer	2.15e-06	5.92e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.97e-06	5.41e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CA—kidney cancer	1.96e-06	5.38e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.76e-06	4.83e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—kidney cancer	1.72e-06	4.72e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CA—kidney cancer	1.72e-06	4.71e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.62e-06	4.44e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.6e-06	4.4e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTEN—kidney cancer	1.5e-06	4.11e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.06e-06	2.9e-05	CbGpPWpGaD
